RadNet, Inc.
corporate_fare Company Profile
RadNet, Inc. (NASDAQ:RDNT) is a publicly traded company in the Life Sciences sector. Wiseek monitors RDNT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- FDA Clears DeepHealth's AI Breast Suite for Cardiovascular Insights, Enhanced Cancer Detection
- RadNet Secures $250M Incremental Term Loan, Reduces Interest Rates on Credit Facilities
- RadNet Secures $250M Incremental Term Loan, Exceeding Prior Target
- RadNet Seeks $200M Incremental Term Loan for Strategic Growth
- RadNet Plans $200M Incremental Term Loan
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for RDNT, detected from its recent SEC filings · based on capital-structure filings through 2026-01-30.
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →